James Sullivan
2023 - enGene Holdings
In 2023, James Sullivan earned a total compensation of $896.2K as Chief Scientific Officer at enGene Holdings, a 104% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $132,936 |
|---|---|
| Option Awards | $371,956 |
| Salary | $379,500 |
| Other | $11,850 |
| Total | $896,242 |
Sullivan received $379.5K in salary, accounting for 42% of the total pay in 2023.
Sullivan also received $132.9K in non-equity incentive plan, $372K in option awards and $11.9K in other compensation.
Rankings
In 2023, James Sullivan's compensation ranked 1,319th out of 2,918 executives tracked by ExecPay. In other words, Sullivan earned more than 54.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,319 out of 2,918 | 55th |
Division Manufacturing | 795 out of 1,608 | 51st |
Major group Chemicals And Allied Products | 526 out of 901 | 42nd |
Industry group Drugs | 513 out of 864 | 41st |
Industry Biological Products, Except Diagnostic Substances | 147 out of 211 | 30th |
Source: SEC filing on April 18, 2024.
Sullivan's colleagues
We found two more compensation records of executives who worked with James Sullivan at enGene Holdings in 2023.
News
MoSys CEO Ronald Glibbery's 2023 pay falls 52% to $400K
November 21, 2024
enGene Holdings CEO Jason Hanson's 2023 pay jumps 238% to $2.2M
April 18, 2024
MoSys CEO Ronald Glibbery's 2022 pay jumps 4,880% to $830K
November 20, 2023
BIO-key International CLO James Sullivan's 2022 pay jumps 84% to $432K
June 9, 2023
MoSys Vice President, General Manager of Memory Products and Director Daniel Lewis' 2021 pay jumps 220% to $799K
November 28, 2022
BIO-key International CEO Michael DePasquale's 2021 pay falls 21% to $277K
May 5, 2022
MoSys CEO Daniel Lewis' 2019 pay jumps 290% to $491K
May 26, 2020